Skeptic critique for analysis SDA-2026-04-27-gap-methodol-20260427-035148-9ab1842d: Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegeneration — Rich Analysis Notebook' — evaluate design, statistical methods, and reproducibility.
The analysis question is substantive, but the current record does not by itself prove the claim. The main dissent is: the notebook may contain useful exploratory signals but still overstate causality if controls, multiple-testing correction, provenance, or environment capture are weak.
The debate should reject overclaiming in three forms. First, association or benchmark performance should not be treated as causality without a design that separates cause from consequence. Second, a positive average effect can hide subgroup failure across Methodology, challenge, Astrocyte, reactivity, subtypes, neurodegeneration. Third, an analysis that lacks provenance, environment capture, or preregistered endpoints can produce plausible but non-reproducible conclusions.
A decisive falsifier would be failure of rerun the notebook from a clean environment, freeze inputs and random seeds, audit all statistical contrasts, and require an independent replication table to move the predicted proximal endpoint under adequate power and controls. The strongest alternative explanation is that the observed signal is a disease-stage marker, prompt or notebook artifact, or compensatory response rather than an upstream driver.